Showing results (51-60 of 154) with videos related to

Sort By:
Pageof 16
Gut Microbes|June 16, 2021
Effect of COVID-19 precautions on the gut microbiota and nosocomial infectionsArmin Rashidi, Maryam Ebadi, Tauseef Ur Rehman, et al.
Leukemia Research|August 21, 2007
Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institutionRafael Santana-Davila, Shernan G Holtan, Gordon W Dewald, et al.
Blood Advances|February 9, 2021
Low 5-year health care burden after umbilical cord blood transplantationJesus Garcia Garcia, Sonya Grillo, Qing Cao, et al.
Cancers|June 12, 2026
Attenuation of Immune Senescence Markers After Intensive Cancer Therapy Through Resistance Training: A Pilot StudyLaura F Newell, Eric Twohey, Jason Sweetnam, et al.
Blood Advances|March 3, 2021
Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomesNajla El Jurdi, Ahmad Rayes, Margaret L MacMillan, et al.
Frontiers in Medical Technology|December 24, 2025
Frailty is associated with low physical activity and poor sleep quality in patients undergoing myeloablative allogeneic hematopoietic cell transplantation: a Fitbit® pilot studyCaryn R Libbert, Fiona He, Najla El Jurdi, et al.
Transplantation and Cellular Therapy|May 16, 2022
Steroid-Sensitive, but Not Steroid-Dependent or Steroid-Resistant Acute Graft-versus-Host Disease, Results in Similar Infection Risk as No Graft-versus-Host Disease following Allogeneic Hematopoietic Cell TransplantationJo-Anne H Young, Najla El Jurdi, Ahmad Rayes, et al.
Blood|January 17, 2015
Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantationShernan G Holtan, Todd E DeFor, Aleksandr Lazaryan, et al.
Blood Advances|February 22, 2022
Lasting shift in the gut microbiota in patients with acute myeloid leukemiaArmin Rashidi, Maryam Ebadi, Tauseef Ur Rehman, et al.
Therapeutic Advances in Hematology|September 4, 2023
A new beginning: can omidubicel emerge as the next, viable alternative donor source?Arpita P Gandhi, Laura F Newell, Richard T Maziarz
Pageof 16